AstraZeneca buys into protein drugs for $200M+
January 7, 2022
WILMINGTON – Pharmaceutical giant AstraZeneca has signed two separate global development and commercialization agreements for drugs that treat a protein disease, signaling that the firm sees the patient segment as […]
chat_bubble0 Comment
visibility1373 Views
AstraZeneca acquires Caelum Biosciences for $150M
October 8, 2021
WILMINGTON – Pharmaceutical giant AstraZeneca has acquired Caelum Biosciences, a small clinical-stage biotechnology company, for $150 million. The New Jersey-based Caelum was founded by New York-based biopharma company Fortress Biotech […]
chat_bubble0 Comment
visibility1403 Views
Premier Digital Partners
© 2024 Delaware Business Times
